The recent discovery that IL-23 and Th17 cells play a major role in the development of chronic intestinal inflammation in mouse models of IBD together with the identification of IL-23R gene polymorphisms that influence IBD susceptibility [64] has provided a new picture of the way the local immune response can promote intestinal tissue damage. The gene discussed is IL23R; the disease is inflammatory bowel disease.